21 July 2021 in Experimental and Clinical Gastroenterology
The article demonstrates the results of a study to study the comparative assessment of the concentration of ammonia in the peripheral blood of patients with a viral infection of COVID-19 against the background of previously existing hepatic pathology and without it. There was a correlation between peripheral blood hyperammonemia and an increase in the concentration of markers of acute inflammation. The relationship between a high degree of hyperammonemia and a severe course / death as a result of the development of a new coronavirus infection in the studied patients was traced. The role of the initial chronic hepatic pathology (including non-alcoholic fatty liver disease) as a factor in the unfavorable course of the new coronavirus infection is highlighted.
26 September 2022 in Ulyanovsk Medico-biological Journal
Vein thrombosis of the lower extremities, especially deep, is an acute condition which develops under the influence of multiple factors. In this case, the immediate threat to the patient’s life is associated with the development of acute pulmonary embolism (PE). A wide range of symptoms accompanied by the underlying disease manifestations determines patient's grave condition, complicates timely diagnosis and treatment, contributes to a poor prognosis and high mortality. Thus, the risk ratio of PE development should be assessed in all patients, regardless of age. The article provides data on the epidemiology, risk factors, clinical features and diagnosis of thromboembolic complications in real clinical practice. The paper describes a clinical case of community-acquired pneumonia in a young man with asymptomatic deep vein thrombosis of the lower extremities and the development of multiple pulmonary embolism. A combination of diseases determined the severity of patient’s state, the challenges of intravital diagnosis of the concomitant pathology and a poor prognosis due to such a combination. The diagnosis was confirmed at autopsy by the detection of various clots in the lung vascular bed.
12 April 2023 in Meditsinskiy sovet = Medical Council
Management of patients with primary osteoarthritis (OA) is often a difficult task due to the specifics of the course of the disease, comorbidity, and low compliance of patients to treatment methods, including symptomatic slow acting drugs (SYSADOA). More than half of the surveyed practitioners (62.2%) express doubts about patients’ adherence to SYSADOA treatment. The described clinical observation demonstrates difficulties in the treatment of primary OA in a patient with comorbidity and low compliance. A three-year course therapy of orally administered SYSADOA did not have a significant effect, and new joints were involved in the process. Thus, the patient was offered a shorter course of therapy (10 injections) with a drug from the SYSADOA group. Its active component is a bioactive extractextract from a small sea fish (Ambene® Bio), created using a unique patented technology. There have been studies of the drug and its clinical efficacy described in literature. In the described case, a short course of therapy contributed to an increase in compliance to treatment. A repeated course of 10 injections every other day was carried out after 6 months. At the same time, the patient refused to take non-steroidal anti-inflammatory drugs. Subjective improvement was confirmed by laboratory and instrumental methods.
1 January 2020 in Transbaikalian Medical Bulletin
Цель. Оценить факторы риска, особенности клинического течения, результатов диагностики и лечения тромбоэмболии легочной артерии в зависимости от применяемых способов терапии. Материалы и методы. В основу работы положен анализ базы данных пациентов с тромбоэмболией легочной артерии, получивших стационарное лечение в БУ «Республиканский кардиологический диспансер» Министерства здравоохранения Чувашской Республики за 6 лет (2012-2018 гг.). В статистической обработке использовались методы описательной статистики. Результаты и выводы. Большая часть пациентов с тромбоэмболией легочной артерии находилась в трудоспособном возрасте. Наиболее частым фактором риска развития тромбоэмболии легочной артерии явился тромбоз глубоких вен нижних конечностей и таза. Хирургические методы лечения доказали свою эффективность в группе пациентов с острой тромбоэмболией высокого и промежуточно-высокого риска ранней смерти. Приводятся описания собственных клинических...
24 March 2020 in Experimental and Clinical Gastroenterology
Introduction. Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used in curing rheumatologic diseases. To minimize the negative impact of NSAIDs on the gastrointestinal tract (GIT), it is essential to consider the patient’s risk factors and to conduct adequate gastroprotection. The main objective of the study was to assess the knowledge of primary care physicians about NSAIDs — associated gastrointestinal lesions, and to analyze the validity of choosing NSAIDs for patients with rheumatic diseases at the outpatient stage.Materials and methods. 100 of outpatient physicians were surveyed. 100 patients with rheumatic diseases referred by general practitioners/physicians for a consultation with a rheumatologist were surveyed and their medical records were analyzed.Results: 28% of rheumatological patients had a low level of risk of complications from the gastrointestinal tract, 53% — moderate level of risk, 19% — high level, but it is not reflected in the medical records. Physicians are not aware enough about the risk factors for NSAID-associated lesions of the gastrointestinal tract. Doctors find it difficult to identify groups of moderate and low risk. In 95% of cases gastroprotective proton pump inhibitorswas conducted regardless of current indications. Rebamipidewas not assigned in any case, although it was mentioned in the survey by 4% of the respondents. Most often, patients with rheumatological pathology are prescribednimesulide (37%), Ketorolac (26%). Coxibe, amtolmetinguacylwere not prescribed by general physicians to a single patient.Conclusion: Physicians are not aware enough about the risk factors for NSAID-associated lesions of the gastrointestinal tract. NSAIDs are chosen without taking into account modern clinical recommendations.
3 September 2022 in Лечащий врач
Diagnosis of Crohn's disease is a complex, often lengthy process, which is based on a consistent differential diagnostic search. A significant proportion of patients with Crohn's disease may develop extraintestinal manifestations. Often, skin lesions precede the manifestation of intestinal symptoms or occur in parallel with intestinal manifestations. Their spectrum is quite wide, and the mechanism of occurrence is heterogeneous. In particular, autoimmune extraintestinal manifestations associated with the activity of the inflammatory process are isolated, which appear along with the main intestinal symptoms of exacerbation and, with the modern appointment of adequate pathogenetic therapy, are resolved in parallel with a decrease in the degree of activity of intestinal inflammation. Skin lesions in inflammatory bowel diseases, according to various authors, occur in 6-43% of cases. Skin changes in inflammatory bowel diseases are explained by common pathogenetic mechanisms: hyperproduction of IL-12 and interferon-gamma synthesized by Th1-lymphocytes, IL-5 and IL-13 produced by Th2-lymphocytes, IL-17 by Th17-lymphocytes. One of the severe skin lesions in Crohn's disease is pyoderma gangrenosum, an inflammatory neutrophilic dermatosis characterized by painful ulcerative skin defects (ulcers of polycyclic outlines with raised edges and covered with necrotic masses) and often associated with diseases of the internal organs. The article describes a clinical case of a patient with Crohn's disease and pyoderma gangrenosum. The stages of differential diagnostic search and treatment are described. The interleukin 12/23 inhibitor ustekinumab has been shown to be highly effective in achieving clinical, laboratory and endoscopic effects already at early stages of treatment. At the same time, in parallel with the healing of the mucosa of the terminal ileum, skin manifestations were also reduced. This clinical case also confirms the importance of such factors as the severity of the course of the disease and the presence of extraintestinal manifestations when choosing the first biological drug for the treatment of Crohn's disease.